189 related articles for article (PubMed ID: 6616963)
1. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.
Funa K; Alm GV; Rönnblom L; Oberg K
Clin Exp Immunol; 1983 Sep; 53(3):716-24. PubMed ID: 6616963
[TBL] [Abstract][Full Text] [Related]
2. Inverse relationship between interferon production by mononuclear leucocytes and oxidative metabolism of neutrophil granulocytes in infection prone children.
Bondestam M; Funa K; Venge P; Alm GV
Clin Exp Immunol; 1985 Apr; 60(1):196-202. PubMed ID: 2408797
[TBL] [Abstract][Full Text] [Related]
3. Association of human leucocyte low responsiveness to inducers of interferon alpha with HLA-DR 2.
Abb J; Zander H; Abb H; Albert E; Deinhardt F
Immunology; 1983 Jun; 49(2):239-44. PubMed ID: 6406360
[TBL] [Abstract][Full Text] [Related]
4. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells and interferon responses in patients with systemic lupus erythematosus.
Tsokos GC; Rook AH; Djeu JY; Balow JE
Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954
[TBL] [Abstract][Full Text] [Related]
6. Interferon and natural killer cells in systemic lupus erythematosus.
Strannegård O; Hermodsson S; Westberg G
Clin Exp Immunol; 1982 Nov; 50(2):246-52. PubMed ID: 6185256
[TBL] [Abstract][Full Text] [Related]
7. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
[TBL] [Abstract][Full Text] [Related]
8. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
Oberg K; Funa K; Alm G
N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
[TBL] [Abstract][Full Text] [Related]
9. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
10. [Comparative studies of human natural IFN-alpha, IFN-beta and IFN-gamma with regard to their effects on in vitro immune responses].
Aoki N; Ohno Y; Imamura M; Matsumoto H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1314-21. PubMed ID: 3089170
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
Edwards BS; Hawkins MJ; Borden EC
Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
[TBL] [Abstract][Full Text] [Related]
12. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
13. In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients.
Fujimiya Y; Wagner RJ; Groveman S; Sielaff K; Kohsaka T; Nakayama M
Ther Immunol; 1995 Feb; 2(1):15-22. PubMed ID: 7553067
[TBL] [Abstract][Full Text] [Related]
14. Suppression of natural killer cell cytotoxicity in the peripheral blood of patients receiving interferon therapy.
Spina CA; Fahey JL; Durkos-Smith D; Dorey F; Sarna G
J Biol Response Mod; 1983; 2(5):458-69. PubMed ID: 6644350
[TBL] [Abstract][Full Text] [Related]
15. Correlation between in vitro and systemic effects of native and recombinant interferons-alpha on human natural killer cell cytotoxicity.
Edwards BS; Hawkins MJ; Borden EC
J Biol Response Mod; 1983; 2(5):409-17. PubMed ID: 6644345
[TBL] [Abstract][Full Text] [Related]
16. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.
Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M
Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Natl Cancer Inst; 1985 Dec; 75(6):1017-23. PubMed ID: 2415742
[TBL] [Abstract][Full Text] [Related]
18. Interferon treatment in patients with malignant carcinoids.
Nobin A; Lindblom A; Månsson B; Sundberg M
Acta Oncol; 1989; 28(3):445-9. PubMed ID: 2742782
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human natural killer cell cytotoxicity by recombinant leukocyte interferon clone A.
Lotzová E; Savary CA; Gutterman JU; Quesada JR; Hersh EM
J Biol Response Mod; 1983; 2(5):482-96. PubMed ID: 6644351
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects.
Lew F; Tsang P; Solomon S; Selikoff IJ; Bekesi JG
J Clin Lab Immunol; 1984 Jul; 14(3):115-21. PubMed ID: 6237206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]